About the project
Clinical Study
Partners
News and events
Publications
Social Media
Links
Archives
2020
2019
2018
2017
2016
Recent
Latest news
| Thursday, August 27th | 0 comments
Herantis Pharma Plc Announces CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months
